Next Article in Journal
Caerin 1.1/1.9 Enhances Antitumour Immunity by Activating the IFN-α Response Signalling Pathway of Tumour Macrophages
Next Article in Special Issue
New Challenges Facing Systemic Therapies of Advanced HCC in the Era of Different First-Line Immunotherapy-Based Combinations
Previous Article in Journal
Prognostic Hematologic Biomarkers Following Immune Checkpoint Inhibition in Metastatic Uveal Melanoma
Previous Article in Special Issue
Chimeric Antigen Receptor Immunotherapy for Solid Tumors: Choosing the Right Ingredients for the Perfect Recipe
 
 
Review

Article Versions Notes

Cancers 2022, 14(23), 5790; https://doi.org/10.3390/cancers14235790
Action Date Notes Link
article pdf uploaded. 24 November 2022 14:11 CET Version of Record https://www.mdpi.com/2072-6694/14/23/5790/pdf-vor
article xml file uploaded 25 November 2022 07:28 CET Original file -
article xml uploaded. 25 November 2022 07:28 CET Update https://www.mdpi.com/2072-6694/14/23/5790/xml
article pdf uploaded. 25 November 2022 07:28 CET Updated version of record https://www.mdpi.com/2072-6694/14/23/5790/pdf
article html file updated 25 November 2022 07:30 CET Original file -
article html file updated 1 March 2023 00:45 CET Update -
article html file updated 3 March 2023 22:40 CET Update https://www.mdpi.com/2072-6694/14/23/5790/html
Back to TopTop